LUO Cheng, et al. Association between serum complement C3 and metabolic syndrome and its components in women with polycystic ovary syndrome. [J]. Journal of Chongqing Medical University 36(4):433-436(2011)
LUO Cheng, et al. Association between serum complement C3 and metabolic syndrome and its components in women with polycystic ovary syndrome. [J]. Journal of Chongqing Medical University 36(4):433-436(2011) DOI: 10.13406/j.cnki.cyxb.2011.04.029.
Association between serum complement C3 and metabolic syndrome and its components in women with polycystic ovary syndrome
Objective:To investigate the association between serum complement C3(C3)and metabolic syndrome(MS)and its components in women with polycystic ovary syndrome(PCOS).Methods:91 women with PCOS and 115 age-matched normal women were enrolled in this study.Anthropometric measurements and biochemical parameters were evaluated to find the relationship between C3 and other parameters.Results:The concentration of C3 was significantly higher in women with PCOS compared with control subjects(1.39± 0.33) g/L vs(1.10±0.22) g/L
P<0.05);it was also higher in subjects with MS or any components of MS in PCOS;and the C3 level rose gradually along with the increase of the number of MS features(P<0.05).Correlation analyses indicated that the C3 was associated positively with BMI
waistline
systolic blood pressure
diastolic blood pressure
fasting plasma glucose
2-h plasma glucose
fasting insulin
triglyceride
total cholesterol
LDL-c and Homa-IR(r=0.65
0.63
0.36
0.29
0.39
0.49
0.56
0.58
0.40
0.32
0.58
P<0.05)
While negatively with M value and HDL-c(r=-0.65
-0.36
P<0.05).Multiple linear regression showed WC and TG(β=0.31
P<0.05)
TG(β=0.23
P<0.05)were significant influential factors for C3.Binary logistic regression analysis showed that subjects in PCOS group were more likely to get MS when C3 increase(P<0.05).Conclusion:High concentration of C3 is a risk factor for MS in women with PCOS.
Identification of shared genetic features and molecular mechanisms of metabolic syndrome and colorectal cancer based on transcriptomic data
Clinical efficacy of Liraglutide combined with metformin in overweight or obese patients with PCOS
Comparison of remission of metformin,pioglitazone and their combination on early abnormal glucose metabolism in patients with polycystic ovary syndrome
A mouse model of polycystic ovary syndrome with abnormal glucose and lipid metabolism induced by dihydrotestosterone combined with high-fat diet
Development and validation of an insulin sensitivity score in female with polycystic ovary syndrome
Related Author
Deng Jielian
Li Kangjie
Zhang Cong
Zhang Yuan
Xie Biao
Zhong Xiaoni
Zheng Wei
Liao Mingyu
Related Institution
Department of Cardiology,The First Affiliated Hospital of Chongqing Medical University
Department of Epidemiology and Health Statistics, School of Public Health, Chongqing Medical University
Department of Endocrinology,The Second Affiliated Hospital of Army Medical University
Department of Endocrinology,The First Affiliated Hospital of Army Medical University
Endocrinology and Metabolism Department,The Second Affiliated Hospital of Chongqing Medical University